Effects on CK, RPE, VAS Scale and Physical Performance of Three Recovery Methods in Elite Basketball Players

March 27, 2023 updated by: University of Cadiz

Acute Effects on Creatine Kinase, Perceived Fatigue and Physical Performance of Different Post-Exercise Recovery Methods in Elite Basketball Players: A Crossover Randomized Controlled Trial

The aim of this study was to compare the effects of cold water intermittent ion (CWI), carbohydrate and protein supplementation (SUPPL), and active recovery (ACT) on creatine kinase (CK), perceptual and performance markers of recovery in elite basketball players after a specific fatigue protocol.

Fifteen elite basketball players participated in this crossover controlled trial. All participants were randomly measured in 4 conditions of the recovery method 1 week apart after a fatigue exercise protocol (~ 45 'of high intensity intermittent effort with specific basketball movements). The recovery methods consist of CWI at 10oC in periods of 2 minutes submerged and 2 minutes out of the water, supplementation with 0.3gr / kg of maltodextrin and 0.2gr / kg of neutral whey protein in 0.5 liters of water, pedaling ACT for 25 minutes at 50% of maximum heart rate or a placebo drink (PLA). The Visual Analogue Fatigue Scale (VAS), Perceived Exercise Rate (RPE), CK and physical performance (jumping, speed, isometric and dynamic tests of resistance to squats) were measured before, after and 24 hours after of the protocol. The VAS scale and RPE were also measured immediately after application of the recovery method. Repeated 2-way post-hoc comparisons of ANOVA and Bonferroni measures were applied, with a significance set at P <0.05.

Study Overview

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cadiz
      • Puerto Real, Cadiz, Spain, 11510
        • Science of Education Faculty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Having at least 10 years of sports practice,
  • Having been training during the season a minimum of four times a week,
  • Not having suffered serious or minor but recently injuries,
  • Having competed and trained regularly in the previous season.

Exclusion Criteria:

  • Suffering an injury during the study period
  • Not having gone through all the treatment groups (CWI, carbohydrate-protein supplementation, active recovery and placebo)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cold-water immersion
Subjects were immersed, in a sitting position where legs were always covered, in cold water at 11ºC in periods of 2 minutes submerged and 2 minutes out of the water at room temperature (25ºC), repeating this process 5 times.
Subjects were immersed, in a sitting position where legs were always covered, in cold water at 11ºC in periods of 2 minutes submerged and 2 minutes out of the water at room temperature (25ºC), repeating this process 5 times
Experimental: Protein-carbohydrates supplementation
Subjects consumed a mixed carbohydrate and protein beverage, composed of 0.3gr/kg of maltodextrin and 0.2gr/kg of neutral whey protein in 0.5 litres of water.
Subjects consumed a mixed carbohydrate and protein beverage, composed of 0.3gr/kg of maltodextrin and 0.2gr/kg of neutral whey protein in 0.5 litres of water. Subject sat for 25 minutes until all recovery methods were completed.
Experimental: Active recovery
Subjects was carried out using a bicycle ergometer. The subjects pedaled for 25 minutes at 50% of the maximum heart rate (HRmax).
Subjects was carried out using a bicycle ergometer. The subjects pedaled for 25 minutes at 50% of the maximum heart rate (HRmax)
Placebo Comparator: Placebo
Subjects drank a water-based drink and sweetener. Both the PLA and SUPPL group sat for 25 minutes until all recovery methods were completed.
Subjects drank a water-based drink and sweetener. Subject sat for 25 minutes until all recovery methods were completed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Creatine Kinase (CK)
Time Frame: 4 Weeks
Blood samples were obtained from the earlobe and collected into capillary tubes. Serum creatine kinase activity was analyzed with Reflotron ® Plus - Roche
4 Weeks
Fatigue perception
Time Frame: 4 Weeks
The VAS fatigue scale (VAS) was used and evaluated on a scale from 1 to 10 (1 = no fatigue and 10 = extremely fatigued).
4 Weeks
Rate of Perceived Exertion
Time Frame: 4 Weeks
The Rate of Perceived Exertion Scale (RPE) was used and evaluated on a scale from 1 to 10 (1 = no exertion and 10 = extremely hard).
4 Weeks
10 meters sprint time
Time Frame: 4 Weeks
10m Sprint Test was used and subjects ran 10m maximally. The subjects had 2 attempts to achieve their best performance with 1 minute of rest between trials. Time was recorded with a video analysis.
4 Weeks
4 x 10 meters agility time
Time Frame: 4 Weeks
4 x 10m Agility Test was used and subjects had to run as fast as possible between two cones 10 meters apart four times. The subjects had 2 attempts to achieve their best performance with 1 minute of rest between trials. Time was recorded with a video analysis.
4 Weeks
Squat Jump
Time Frame: 4 Weeks
The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). In squat jump, the subjects were asked to keep their hands on their hips and beginning the jump with a 90º knee flexion, without countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials.
4 Weeks
Counter Movement Jump
Time Frame: 4 Weeks
The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). In countermovement jump, subjects were only asked to keep their hands on their hips and jump as high as possible, with countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials.
4 Weeks
Abalakov Jump
Time Frame: 4 Weeks
The flight time in jumps height and its maximal speed were used as a measure of maximal muscle power and was measured on a force platform (Quattro Jump, Kristler). Abalakov jump was performed with free arms movement and countermovement. Subjects had 2 attempts to achieve their best jump with 3 minutes of rest between trials.
4 Weeks
Half Squat Isometric Strength
Time Frame: 4 Weeks
In the maximal isometric strength test, the subjects performed a maximal isometric contraction in the half squat exercise, with 90º knee flexion. The strength of the subjects was measured with a force platform on which the exercise was performed. The subjects were asked to perform the maximal strength possible since the start and to not stop until a signal. They had 2 attempts to achieve their best performance with 3 minutes of rest between trials.
4 Weeks
Half Squat Dynamic Strength
Time Frame: 4 Weeks
In the dynamic strength test, the subjects performed 6 repetitions of a half squat, using a Smith Machine, with the load that represented the 70% of RM (0.65 m·s) at baseline in the half squat exercise. The mean velocity was measured with a linear encoder and it was registered the fastest repetition. The subjects were asked to perform the concentric action as fast as possible. They had 2 attempts to achieve their best performance with 3 minutes of rest between trials.
4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jesús G Ponce, PhD, University of Cádiz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

March 28, 2017

Study Registration Dates

First Submitted

March 27, 2023

First Submitted That Met QC Criteria

March 27, 2023

First Posted (Actual)

April 10, 2023

Study Record Updates

Last Update Posted (Actual)

April 10, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Placebo

Clinical Trials on Cold-water immersion

3
Subscribe